What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen?: Examinations and Answers via Computer Simulations

Author： Ronald C. Reed   Sandeep Dutta  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.9, 2004-01, pp. : 509-521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug: As Shown by Once-Daily Divalproex-ER

By Dutta Sandeep   Reed Ronald C.  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 681-690

Adis International

Access to resources Recommend Favorite

Once- Versus Twice-Daily Tacrolimus: Are the Formulations Truly Equivalent?

By Barraclough Katherine A.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1561-1577

Adis International

Access to resources Recommend Favorite

Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

By Pea Federico  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 147-152

Adis International

Access to resources Recommend Favorite

Once-daily carmoterol challenges twice-daily formoterol in asthma

By  

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Once-daily ciclesonide equals twice-daily fluticasone for asthma

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite